Basel Medical Group Ltd (BMGL) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Basel Medical Group Ltd (BMGL:NASDAQ), powered by AI.

Current Price
$0.59
Sector
Healthcare
What is the Basel Medical Group Ltd stock price forecast?

Basel Medical Group Ltd is currently trading at $0.59. View real-time AI analysis on Alpha Lenz.

What is Basel Medical Group Ltd insider trading activity?

View the latest insider trading data for Basel Medical Group Ltd on Alpha Lenz.

What is Basel Medical Group Ltd's P/E ratio?

View Basel Medical Group Ltd's valuation metrics on Alpha Lenz.

Basel Medical Group Ltd

NASDAQ · BMGL
$0.59+0.01(+2.06%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Basel Medical Group Ltd's future dividend policy...
Alpha Chat Insight

Basel Medical Group Ltd's ROE is -163.7%. Explore profitability and growth together.

Ask for details

Company Overview

Basel Medical Group Ltd is a healthcare services provider headquartered in Singapore, operating primarily through its specialized medical clinics. The company focuses on general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, offering procedures such as knee and hip replacements, spine surgery, minimally invasive techniques, and comprehensive consultations and diagnostics. Basel Medical Group has established itself within Singapore's healthcare sector and recently expanded its presence through the acquisition of Bethesda Medical Pte. Ltd., a move that broadened its service portfolio to include diagnostic imaging, outpatient care, occupational health, women's health, mental health, and seafarer health services. This integration aims to streamline referrals and enhance patient outcomes throughout the region. Founded in 2001 and incorporated as a public entity in 2023, Basel Medical Group plays an important role in meeting the growing healthcare needs of Southeast Asia by combining specialized care with broader outpatient and preventive services, positioning itself as a dynamic participant in the regional medical landscape.

CEODr. Yen Feng Chhoa M.D.
SectorHealthcare
IndustryMedical Care Facilities
Employees32

Company Statistics

FY 2025

Profile

N/AMarket Cap
$11.32MRevenue
0.00Shares Out
32Employees

Margins

77.45%Gross
6.01%EBITDA
-19.22%Operating
-97.65%Pre-Tax
-93.96%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

11.57%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-60.80%ROA
-163.67%ROE
-62.02%ROIC

Financial Health

$3.04MCash & Cash Equivalents
$10.20MNet Debt
243.50%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Basel Medical Group Ltd (ticker: BMGL) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 32 employees.

The current price is $0.59 with a P/E ratio of -x and P/B of -x.

ROE is -163.67% and operating margin is -19.22%. Annual revenue is $11M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Basel Medical Group Ltd (BMGL) Stock Forecast 2026 $0.59 — Price, Financials & Analyst Targets | Alpha Lenz